These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4008171)

  • 1. Comparative radiopharmacokinetics of 18F-5-fluorouracil administered i.v. to rats bearing a mammary tumor.
    Shani J; Manaka RC; Young D; Cohen JL; Wolf W
    Int J Nucl Med Biol; 1985; 12(1):9-12. PubMed ID: 4008171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and distribution studies with radiolabeled 5-fluorouracil.
    Young D; Vine E; Ghanbarpour A; Shani J; Siemsen JK; Wolf W
    Nuklearmedizin; 1982 Feb; 21(1):1-7. PubMed ID: 6281741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats.
    Shani J; Wolf W; Schlesinger T; Atkins HL; Bradley-Moore PR; Casella V; Fowler JS; Greenberg D; Ido T; Lambrecht RM; MacGregor R; Mantescu C; Neirinckx R; Som P; Wolf AP; Wodinsky I; Meaney K
    Int J Nucl Med Biol; 1978 Mar; 5(1):19-28. PubMed ID: 207653
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals.
    Abe Y; Fukuda H; Ishiwata K; Yoshioka S; Yamada K; Endo S; Kubota K; Sato T; Matsuzawa T; Takahashi T; Ido T
    Eur J Nucl Med; 1983; 8(6):258-61. PubMed ID: 6223818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-radiopharmacokinetics of [18F]-5-fluorouracil in a mouse bearing two colon tumors with a different 5-fluorouracil sensitivity: a study for a correlation with oncological results.
    Visser GW; van der Wilt CL; Wedzinga R; Peters GJ; Herscheid JD
    Nucl Med Biol; 1996 Apr; 23(3):333-42. PubMed ID: 8782245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of 2- and 4-[203Hg]-estradiol in mammary-tumor-bearing rats.
    Shani J; Lieberman LM; Samuni A; Schlesinger T; Cais M
    Int J Nucl Med Biol; 1982; 9(4):251-8. PubMed ID: 7186497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats.
    Bading JR; Yoo PB; Fissekis JD; Alauddin MM; D'Argenio DZ; Conti PS
    Cancer Res; 2003 Jul; 63(13):3667-74. PubMed ID: 12839957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics.
    Bading JR; Alauddin MM; Fissekis JD; Shahinian AH; Joung J; Spector T; Conti PS
    J Nucl Med; 2000 Oct; 41(10):1714-24. PubMed ID: 11038003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of 5-fluorouracil anabolism by methotrexate and trimetrexate in two rat solid tumor models, Walker 256 carcinosarcoma and Novikoff hepatoma, as evaluated by 19F-magnetic resonance spectroscopy.
    Katzir I; Shani J; Wolf W; Chatterjee-Parti S; Berman E
    Cancer Invest; 2000; 18(1):20-7. PubMed ID: 10701363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
    Dimitrakopoulou-Strauss A; Strauss LG; Schlag P; Hohenberger P; Irngartinger G; Oberdorfer F; Doll J; van Kaick G
    J Nucl Med; 1998 Mar; 39(3):465-73. PubMed ID: 9529293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study.
    Brix G; Bellemann ME; Haberkorn U; Gerlach L; Lorenz WJ
    Nucl Med Biol; 1996 Oct; 23(7):897-906. PubMed ID: 8971857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.
    Kissel J; Brix G; Bellemann ME; Strauss LG; Dimitrakopoulou-Strauss A; Port R; Haberkorn U; Lorenz WJ
    Cancer Res; 1997 Aug; 57(16):3415-23. PubMed ID: 9270007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human soluble tumor-associated antigens promote the suppression of rat mammary tumors by 5-fluorouracil and stimulate the functional activity of immune organs: Experimental and morphological studies.
    Kossoy G; Ben-Hur H; Avinoach I; Alhayany A; Shneider DF; Zusman I
    Int J Mol Med; 2003 Nov; 12(5):797-801. PubMed ID: 14533012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.
    Berne MH; Gustavsson BG; Almersjö O; Spears PC; Frösing R
    Cancer Chemother Pharmacol; 1986; 16(3):237-42. PubMed ID: 3698165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
    Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
    NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of omega-3 and omega-6 polyunsaturated fatty acids on protein metabolism in rats bearing the mammary adenocarcinoma.
    Wan JM; Istfan NW; Chu CC; Blackburn GL; Bistrian BR
    Metabolism; 1991 Jun; 40(6):577-84. PubMed ID: 1907711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
    Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
    Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative].
    Shirasaka T; Fukushima M; Shimamoto Y; Kimura Y; Ohshimo H; Imaoka T; Kimura A; Utsunomiya T; Fujii S
    Gan To Kagaku Ryoho; 1990 May; 17(5):1051-8. PubMed ID: 2334171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect and tumor level of 5-fluoro-2'-deoxyuridylate following oral administration of tetradecyl 2'-deoxy-5-fluoro-5'-uridylate.
    Nakajima Y; Iigo M; Hoshi A
    Anticancer Drugs; 1992 Jun; 3(3):289-92. PubMed ID: 1525410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography.
    Finj C; Sadée W
    Cancer Chemother Rep; 1975; 59(2 Pt 1):279-86. PubMed ID: 1097091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.